The lipid panel is the standard cholesterol blood test, measuring four primary lipid components: total cholesterol, LDL (“bad” cholesterol), HDL (“good” cholesterol), and triglycerides. Most adults have had a lipid panel as part of cardiovascular risk screening, particularly after age 40 when atherosclerotic risk increases. The numbers drive decisions about lifestyle changes, statin therapy, and other cardiovascular interventions. Understanding what each value means and how they’re interpreted in context is essential for participating in your own care.
What the lipid panel measures
The standard lipid panel measures:
- Total cholesterol: Sum of all cholesterol fractions
- LDL cholesterol: Low-density lipoprotein, atherogenic
- HDL cholesterol: High-density lipoprotein, protective
- Triglycerides: Blood fats
- Non-HDL cholesterol (calculated): Total minus HDL
- Total/HDL ratio (calculated): Risk indicator
Many labs add additional calculated values like very-low-density lipoprotein (VLDL) and triglyceride/HDL ratio. Advanced lipid testing including ApoB and lipoprotein(a) provides more nuanced cardiovascular risk assessment but isn’t part of standard panels.
Reference ranges and risk categories
Per American Heart Association and ACC guidelines:
Total cholesterol:
- Desirable: under 200 mg/dL
- Borderline high: 200-239 mg/dL
- High: 240+ mg/dL
LDL cholesterol:
- Optimal: under 100 mg/dL
- Near optimal: 100-129 mg/dL
- Borderline high: 130-159 mg/dL
- High: 160-189 mg/dL
- Very high: 190+ mg/dL
HDL cholesterol:
- Low (risk factor): under 40 mg/dL men, under 50 mg/dL women
- Acceptable: 40-59 mg/dL
- High (protective): 60+ mg/dL
Triglycerides:
- Normal: under 150 mg/dL
- Borderline high: 150-199 mg/dL
- High: 200-499 mg/dL
- Very high: 500+ mg/dL
Why LDL gets the most attention
LDL cholesterol is the primary driver of atherosclerotic cardiovascular disease — the plaque buildup in arteries that causes heart attacks and strokes. Decades of clinical trials have established that lowering LDL reduces cardiovascular events. Statins, the most widely prescribed cholesterol medications, primarily lower LDL.
The treatment threshold isn’t a fixed LDL number but depends on overall cardiovascular risk. Patients with established cardiovascular disease, diabetes, or strong family history may benefit from LDL lowering even at “normal” levels. The ACC/AHA Risk Calculator estimates 10-year cardiovascular risk and informs treatment decisions.
HDL — protective but not a target
HDL cholesterol is associated with cardiovascular protection — higher levels correlate with lower risk. However, drugs that specifically raise HDL haven’t shown cardiovascular benefit in clinical trials. The current evidence supports HDL as a risk marker rather than a treatment target.
HDL can be raised through exercise, weight loss, modest alcohol consumption, and smoking cessation. Pharmacological HDL raising has fallen out of favor as a treatment strategy.
Triglycerides and metabolic health
Elevated triglycerides reflect metabolic problems — insulin resistance, excess carbohydrate or alcohol intake, obesity, type 2 diabetes. Very high triglycerides (500+ mg/dL) increase pancreatitis risk and warrant aggressive treatment. Moderately elevated triglycerides are addressed primarily through lifestyle (weight loss, dietary changes, exercise) and treatment of underlying conditions.
Fasting vs non-fasting lipid panels
Traditional lipid panels required 9-12 hours of fasting. Recent guidelines from the American Heart Association and other organizations have validated non-fasting lipid panels for most clinical purposes. Fasting may still be preferred when triglycerides are very high or when LDL calculation precision matters.
If fasting is requested, water is permitted. Most patients schedule lipid panels as morning appointments after overnight fasting.
When to start cholesterol screening
Per ACC/AHA guidelines:
- Screening typically begins at age 20 with risk assessment
- Annual screening for patients with elevated risk factors
- Every 4-6 years for low-risk adults
- Earlier and more frequent screening with family history of premature cardiovascular disease
The USPSTF recommendations differ slightly, with statin therapy considerations starting at age 40.
Frequently Asked Questions
Do I need to fast for a lipid panel?
Not always. Recent guidelines validate non-fasting panels for most purposes. Your provider may request fasting in specific scenarios.
What’s a “normal” cholesterol number?
Total cholesterol under 200 mg/dL is generally desirable, but LDL and risk context matter more than total cholesterol alone. Treatment decisions depend on overall cardiovascular risk, not just numbers.
Should I take a statin if my LDL is high?
Depends on your overall cardiovascular risk. Patients with known cardiovascular disease, diabetes, very high LDL (190+), or significant 10-year risk typically benefit. Discuss with your provider.
Can I lower cholesterol naturally?
Lifestyle changes reduce LDL by 5-15% in many patients. Saturated and trans fat reduction, weight loss, exercise, and Mediterranean-style diet all help. Pharmacological therapy is more potent but isn’t always needed.
How often should I get a lipid panel?
Every 4-6 years for low-risk adults; annually for patients with elevated cardiovascular risk or on cholesterol medications.
The bottom line on the lipid panel
The lipid panel measures the four primary lipid components driving cardiovascular risk assessment. LDL is the primary treatment target; HDL is a risk marker; triglycerides reflect metabolic health. Treatment decisions depend on overall cardiovascular risk rather than individual numbers alone. Discuss your results with your provider in the context of your family history, lifestyle, and other risk factors. For more on cardiovascular risk markers, see our ApoB test guide and Lipoprotein(a) guide.